Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Peters

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 2, 2013
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesCraig J Currie, Chris D Poole, Marc Evans, et al.
Cardiovascular Diabetology|January 21, 2009
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational studyPeter Sharplin, Jason Gordon, John R Peters, et al.
Cardiovascular Diabetology|February 18, 2009
Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysisPeter Sharplin, Jason Gordon, John R Peters, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 24, 2015
Comparative Risk Assessment of Formulation Changes in Generic Drug Products: A Pharmacology/Toxicology PerspectiveSree Rayavarapu, Elena Braithwaite, Robert Dorsam, et al.
Current Medical Research and Opinion|October 4, 2005
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetesRuth E Davis, Malcolm Morrissey, John R Peters, et al.
Diabetes Care|April 30, 2003
Effect of 2-week treatment with pirenzepine on fasting and postprandial glucose concentrations in individuals with type 2 diabetesBasil G Issa, Nichola Davies, Kerenza Hood, et al.
Dermatologic Therapy|May 21, 2009
Generic drugs--safe, effective, and affordableJohn R Peters, Dena R Hixon, Dale P Conner, et al.
Diabetes Research and Clinical Practice|August 28, 2004
Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before deathCraig J Currie, Christopher Ll Morgan, Simon Dixon, et al.
Diabetes Research and Clinical Practice|January 15, 2005
The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complicationsCraig J Currie, Christopher Ll Morgan, Simon Dixon, et al.
Free Radical Biology & Medicine|November 26, 2002
Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitusGareth W Davison, Lindsay George, Simon K Jackson, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|February 2, 2013
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesCraig J Currie, Chris D Poole, Marc Evans, et al.
Cardiovascular Diabetology|January 21, 2009
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational studyPeter Sharplin, Jason Gordon, John R Peters, et al.
Cardiovascular Diabetology|February 18, 2009
Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysisPeter Sharplin, Jason Gordon, John R Peters, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 24, 2015
Comparative Risk Assessment of Formulation Changes in Generic Drug Products: A Pharmacology/Toxicology PerspectiveSree Rayavarapu, Elena Braithwaite, Robert Dorsam, et al.
Current Medical Research and Opinion|October 4, 2005
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetesRuth E Davis, Malcolm Morrissey, John R Peters, et al.
Diabetes Care|April 30, 2003
Effect of 2-week treatment with pirenzepine on fasting and postprandial glucose concentrations in individuals with type 2 diabetesBasil G Issa, Nichola Davies, Kerenza Hood, et al.
Dermatologic Therapy|May 21, 2009
Generic drugs--safe, effective, and affordableJohn R Peters, Dena R Hixon, Dale P Conner, et al.
Diabetes Research and Clinical Practice|August 28, 2004
Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before deathCraig J Currie, Christopher Ll Morgan, Simon Dixon, et al.
Diabetes Research and Clinical Practice|January 15, 2005
The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complicationsCraig J Currie, Christopher Ll Morgan, Simon Dixon, et al.
Free Radical Biology & Medicine|November 26, 2002
Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitusGareth W Davison, Lindsay George, Simon K Jackson, et al.
Pageof 3